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Abstract 
Aims: The aims were to use the rs1229984 variant associated with alcohol consumption as an 
instrument for alcohol consumption to test the causality of the association of alcohol consumption 
with hay fever, asthma, allergic sensitization, and serum total IgE. 
Design: Observational and Mendelian randomization analyses using genetic variants as unbiased 
markers of exposure to estimate causal effects, subject to certain assumptions. 
Setting: Europe. 
Participants: We included a total of 466434 persons aged 15–82 years from 17 population-based 
studies conducted from 1997–2015. 
Measurements: The rs1229984 (ADH1B) was genotyped, alcohol consumption, hay fever and 
asthma were self-reported. Specific and total IgE were measured from serum samples.  
Findings: Observational analyses showed that ever-drinking vs. non-drinking, but not amount of 
alcohol intake, was positively associated with hay fever and inversely associated with asthma but 
not with allergic sensitization, or serum total IgE. However, Mendelian randomization analyses did 
not suggest that the observational associations are causal. The causal odds ratio (OR) per 
genetically assessed unit of alcohol/week was an OR=0.91 (95% confidence interval (CI): 0.81, 
1.02; p=0.101) for hay fever, an OR=0.90 (95% CI: 0.79, 1.02; p=0.095) for asthma, an OR=0.97 
(95% CI: 0.80, 1.17; p=0.763) for allergic sensitization, and a 4.7% change (95% CI: -5.5%, 14.9%; 
p=0.366) for total IgE. 
Conclusions: Ever-drinking vs. not drinking was in observational analyses positively associated 
with hay fever, and negatively associated with asthma. However, the Mendelian randomization 
results were not consistent with these associations being causal. 
 
Keywords: Alcohol, allergic disease, allergic sensitization, asthma, hay fever.
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Introduction 
Alcohol is a strong immune modulating factor (1, 2). Previous observational studies have shown 
that moderate and excessive alcohol intake is associated with higher serum levels of total 
immunoglobulin E (IgE) (3-13). Likewise, alcohol consumption in pregnancy is associated with an 
increase in cord blood IgE levels from the newborn (14). Some epidemiologic studies have found a 
positive association between alcohol consumption and allergic sensitization (9, 12) but other studies 
have not (6, 8, 15). Regarding allergic disease, alcohol consumption was positively associated with 
the risk of developing perennial allergic rhinitis (16), and alcohol consumption during pregnancy 
may increase the risk of atopic dermatitis in the offspring (17). In addition, alcohol is a trigger of 
hypersensitivity reactions and can cause asthma in genetically predisposed individuals (18). The 
possible mechanisms by which alcohol consumption could affect allergic sensitization and levels of 
total IgE may include a direct effect of alcohol or its metabolites on lymphocyte subsets with 
subsequent T helper (Th)1/Th2 cytokine imbalance, or an indirect effect due to alcohol-induced 
permeability of the gut mucosa to endotoxin of other bacterial products (1, 3, 5, 10, 19).   
Causal inference from conventional epidemiologic studies between alcohol 
consumption and allergic respiratory disease is difficult due to the potential confounding and 
reverse causation. Mendelian randomization examines causality by using genetic variants, typically 
single nucleotide polymorphism (SNP), as instruments for exposures. It assumes random allocation 
of genes from parents to offspring and no direct association between genotype and outcome and 
will not be associated with the confounding factors that are inherent in conventional observational 
studies. The enzyme alcohol dehydrogenase (ADH) oxidizes alcohol to acetaldehyde. The more 
active forms of this enzyme are protective against drinking, because they cause higher levels of 
acetaldehyde. In European samples, the rs1229984 variant in the ADH1B gene is most strongly 
associated with alcohol phenotypes, and the protective A-allele frequency is approximately 2–5% in 
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Europeans (20). The rs1229984 has previously been used as instrument for alcohol consumption in 
Mendelian randomization studies to examine the effect of alcohol consumption in cardiovascular 
disease (20).  
Persons sensitized to inhalant allergens as, measured by serum specific 
immunoglobulin E (IgE), are at risk of developing allergic respiratory disease. Serum specific IgE 
positivity to inhalant allergens are an accepted objective tests of allergic respiratory disease in 
clinical assessment and in epidemiological studies. The aims were to use the rs1229984 variant as 
an instrument for alcohol consumption to test the causality of the association of alcohol 
consumption with 1) hay fever, 2) asthma, 3) allergic sensitization, and 4) serum total IgE, in a 
Mendelian randomization meta-analysis of 466434 participants across 17 studies. We examined the 




We performed multicenter traditional observational and Mendelian randomization analyses to 
determine whether alcohol consumption causally affects allergic respiratory disease, and asthma, 
and estimate the magnitude of the associations. 
 
Study populations 
We included 466434 participants (including 98786 cases of hay fever, 53796 cases of asthma, and 
6053 cases of allergic sensitization) of self-reported or genetically determined European ancestry 
aged ≥16 years from the following 17 studies: The British 1958 birth cohort (1958 BC), 
Copenhagen City Heart Study (CCHS), the Danish Monitoring of trends and determinants in 
Cardiovascular Diseases (MONICA) Study (the Dan-Monica10 Study), the Allergy98 Study, 
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Genomics of Overweight Young Adults (GOYA) Males, the Health2006 Study, the Inter99 Study, 
the Cooperative Health Research in the Region of Augsburg (KORA) Study, the MRC National 
Survey of Health and Development (NSHD) Study, the 1936 Cohort, the UK Biobank, the 
Netherlands Epidemiology of Obesity (NEO) Study, the PROspective Study of Pravastatin in the 
Elderly at Risk (PROSPER), the Rotterdam Study, the Studies of Health in Pomerania (SHIP and 
SHIP TREND), and the DanFunD Study. Further details of these studies are provided in online 




Rs1229984 is located in the alcohol dehydrogenase 1B gene (ADH1B). It encodes the ADH1B 
enzyme that is the main metabolizer of alcohol (20). Due to the low prevalence of the rs1229984 A-
allele, we recoded the genetic variant according to a dominant model into major homozygotes 
(alcohol-increasing genotype) vs. heterozygotes and minor homozygotes combined (alcohol-
decreasing genotypes). Description of the method for genotyping within each study is provided in 
supplementary material. Genotype frequencies and Hardy-Weinberg equilibrium levels are shown 
in Table S3. The minor allele frequency ranged from 0.008–0.070 across studies. The SNP was 
directly genotyped in each study, except for the DanFunD study, KORA, the 1936 Cohort, the 
Rotterdam study, and the NEO study (Supplementary Material). 
 
Hay fever, asthma, allergic sensitization, lung function, and serum total IgE 
Data on hay fever and asthma were obtained from interviews or questionnaires according to 
Supplemental Table S4. Our first choice of definition/diagnosis was lifetime/ever, but if not 
available we used a diagnosis in the past 12 months or longer (Table S4). Allergic sensitization was 
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defined by serum specific IgE positivity to at least one of the tested inhalant allergens (Table S4). 
We used the cut-offs for positivity generally recommended by the manufacturer. Serum total IgE 
was measured by a number of assays as detailed in Supplementary Material and Table S2 and S4.  
 
Alcohol intake 
We used self-reported alcohol status (non-drinker or ever-drinker) and units of alcohol consumed 
per week (either by interview or questionnaire), reported at the same time or as close as possible to 
the assesment of allergic respiratory disease (see Supplementary Material). 
 
Statistical analyses 
Statistical analyses were performed with SAS, version 9.4 (SAS Institute Inc., Cary, NC, USA), 
STATA, version 12 (StataCorp, College Station, TX, USA), the statistical software R, version 3.3.3 
(http://www.r-project.org/), and Quanto, version 1.2 (University of Southern California, US). The p-
values are two-tailed, and statistical significance was defined as P<0.05. Serum total IgE was log-
transformed in the regression analyses to fulfill requirements on normality.  
With an assumed protective allele frequency of 2% for the rs1229984 genotype, we 
calculated the required number of cases and controls among ever-drinkers in Quanto 1.2 (University 
of Southern California, US) for a range of effect sizes prior to the study. For example, with a power 
of 0.80 we would need approximately 6000 and 18000 ever-drinkers with and without hay fever, 
respectively, to detect an odds ratio of 0.85 and 14000 and 42000 ever-drinkers with and without 
hay fever, respectively, to detect an odds ratio of 0.90 among carriers of the protective allele 
compared to non-carriers. Likewise, for the natural logarithm of serum total IgE (mean=3.4 and 
standard deviation=1.5) as outcome, we would need approximately 40000 ever-drinkers to detect an 
R2=0.0002/ß=-0.10 for carriers vs. non-carriers of the protective allele. The sample size needed to 
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estimate an effect on, e.g., hay fever per genetically determined drink of alcohol with a power of 
0.8, type 1 error rate og 0.05, variance in amount of alcohol explained by the SNP of 0.0045, and an 
OR=1.3 of hay fever per standard deviation of amount of alcohol, was calculated to be N=293025 
(21). 
 The study was performed as a multicenter meta-analysis. We provided the study 
representatives with an invitation to contribute to the study, an analysis protocol, and a Stata-script 
to be used in the analyses. The study results were combined in random effects meta-analyses. 
Participants with missing value in one or more variables were excluded. Analyses were performed 
in all participants and in strata defined by alcohol status. The main analyses were performed in 
ever-drinkers. The analyses were adjusted for age, gender, and genetic principal components if 
available (British 1958 Birth Cohort, the NEO study, and the UK Biobank). 
 First, observational analyses of the associations of alcohol status and intake with hay 
fever, asthma, allergic sensitization, and serum total IgE were assessed by logistic and linear 
regression analyses. Second, Mendelian randomization analyses were performed. The associations 
of the alcohol-associated SNP and alcohol status, alcohol intake, hay fever, asthma, allergic 
sensitization, and serum total IgE were assessed using linear and logistic regression. The estimates 
from each study were meta-analyzed using the ‘metan’ command in Stata. Heterogeneity was 
examined by the I2 statistic. The instrumental variable (IV) analyses were performed by the 
“MendelianRandomization” package in R using the inverse variance-weighted method (“mr_ivw”), 
similar to the ratio method for a single IV. These were performed regardless of statistical 
significance to show the size of the estimates. 
 Since the primary definition of hay fever in the UK Biobank also included eczema, we 
performed additional analyses using different definitions (See Supplementary). A part of the UK 
Biobank Study, the UK Biobank Lung Exome Variant Evaluation (UK BiLEVE) study, was 
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sampled according to lung function and smoking status, and we performed sensitivity analyses 
excluding this study (See Supplementary). Analyses including UK Biobank data and 1958 BC 
where the alcohol genotype was directly genotyped, and adjustments were made for principal 
components are shown in Supplementary Figures S1–S5.  
 
Results 
Descriptive statistics for each of the study populations are shown in Table 1 and Supplementary 
Table S1. Minor allele frequencies and Hardy Weinberg Equilibrium p-values are shown in 
Supplementary Table S3. There was a statistically significant positive association between the 
rs1229984 genotype (major homozygotes vs. minor homozygotes and heterozygotes) and higher 
alcohol intake (logarithmically transformed) (Figure 1). 
 
Observational analysis  
Ever-drinking, but not alcohol intake, was positively associated with hay fever. Ever-drinking, but 
not alcohol intake, was inversely associated with asthma (Figure 2). The observed associations of 
ever-drinking with hay fever and asthma, respectively, were rather consistent across studies 
(Supplementary Figures S6–S7). For alcohol intake and hay fever and asthma, there was some 
heterogeneity across studies (Supplementary Figures S10–S11). Ever-drinking and alcohol intake 
were positively, though ever-drinking statistically non-significantly, associated with allergic 
sensitization (Figure 2), with low heterogeneity across studies (Supplementary Figures S8 and S12). 
The number of participants in the analyses of allergic sensitization was substantially lower 
(N=19443–21213, Figure 2) than for hay fever and asthma. Intake of alcohol, but not ever-drinking, 
was significantly associated with increasing serum total IgE and log(total IgE) (Figure 3).   
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Mendelian randomization analysis 
The rs1229984 genotype associated with higher alcohol intake (major homozygotes vs. minor 
homozygotes and heterozygotes) was not significantly associated with hay fever, asthma, allergic 
sensitization, or log(total IgE) in ever- or non-drinkers (Supplementary Figure S2–S5). 
 The estimate for the first stage regression (SNP-exposure) among ever-drinkers 
(calculated in the UK Biobank data) was β=1.324 (standard error (SE)=0.086, N=292158) units of 
alcohol for alcohol-increasing genotype vs. alcohol-decreasing genotypes. The estimates for the 
second stage regressions (SNP-outcome) were as follows: hay fever β= -0.130 (SE=0.079); asthma 
β= -0.144 (SE=0.086); allergic sensitization β= -0.038 (SE=0.128); and log(total IgE) β=0.062 
(SE=0.069).  
 There was no clear evidence that genetically assessed intake of alcohol was associated 
with risk of hay fever, asthma, or allergic sensitization. The causal estimates, per unit of alcohol 
consumed, were an OR=0.907 (95% CI: 0.806,1.019; p=0.101) for hay fever, an OR=0.897 (95% 
CI: 0.790, 1.019; p=0.095) for asthma, and an OR=0.971 (95% CI: 0.804, 1.174; p=0.763) for 
allergic sensitization. 
 Genetically assessed higher alcohol intake was not associated with total IgE (Figure 
3). The causal estimate of log(total IgE) for ever-drinkers was β=0.047 (95% CI: -0.055, 0.149; 
p=0.366) per unit of alcohol, which reflects an approximate 4.7% change (95% CI: -5.5%, 14.9%; 
p=0.366) in total IgE per unit of alcohol consumed (Figure 3).  
Analyses including UK Biobank data and 1958 BC where the alcohol genotype was 
directly genotyped, and adjustments were made for principal components (Supplementary Figures 
S1–S5) let to similar conclusions. 
 The primary definition of hay fever in UK Biobank suggested an OR=0.987 (95% CI: 
0.952, 1.023, p=0.474, N=394883) for ever-drinkers with alcohol increasing genotype. Using self-
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reported hay fever medication as alternative definition of hay fever (see Supplementary Material) 
suggested an OR=0.977 (95% CI: 0.876, 1.089, p=0.671, N=394883). Using self-reported hay fever 
classified as serious illness as alternative definitions of hay fever suggested an OR=1.011 (95% CI: 
0.934, 1.093, p=0.793, N=394883). Hay fever in UK Biobank without the UK Biobank Lung 
Exome Variant Evaluation (UK BiLEVE) study (22) (see Supplementary Material) suggested an 
OR= 0.984 (95% CI: 0.947, 1.022, p=0.398, N=351833).  
 Asthma in the UK Biobank without BiLEVE suggested an OR=0.989 (95% CI: 0.939, 
1.041, p=0.666, N=351833), whereas asthma in the entire UK Biobank suggested an OR= 0.995 
(95% CI: 0.949, 1.044, p=0.845, N=394883) for the alcohol increasing genotype.  
 
Discussion 
We found that ever-drinking was observationally positively associated with hay fever and inversely 
associated with asthma, but there was no clear evidence of association with allergic sensitization or 
total IgE, and in Mendelian randomisation analyses, genetically assessed intake of alcohol was not 
associated with hay fever, asthma, allergic sensitization, or serum total IgE, suggesting that the 
observational associations are not causal. 
 Oldenburg et al found that alcohol feeding decreased airway hyper-responsiveness and 
allergic airway inflammation in allergic mice, suggesting that there may be an important role 
for alcohol in the modulation of asthma (23). Few studies have examined the possible 
bronchodilator effect of alcohol in humans (24, 25). Ayres et al found that intake of 40 ml of sherry 
was consistent with an increase in peak expiratory flow rate in 19 patients with asthma but not in 16 
controls (25). This bronchodilation was more marked in patients with peak flow rate less than 50% 
of the predicted rate. Lieberoth et al found that alcohol intake was associated with incident asthma 
in adults with a U-shaped association where the lowest risk of asthma was observed in the group 
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with a moderate intake of alcohol (26). There is evidence that acetaldehyde increases histamine 
release from mast cells in both animal and human studies (10). In Japanese populations, in which a 
genetic variant causing high levels of acetaldehyde is very common, alcohol is in these genetically 
predisposed individuals accompanied by bronchoconstriction and flushing (alcohol-induced asthma 
and Oriental flushing) following alcohol intake. Whether the alcohol-induced Th2-skewing of the 
human immune response is mediated trough acetaldehyde is not fully known. 
 A study by Siu et al found that light to moderate alcohol drinkers had better lung 
function than abstainers did. This was independent of smoking and evident lung or heart disease 
suggesting that drinking moderate amounts of alcohol may benefit lung function (27). Frantz et al 
found that alcohol and heavy drinking in particular had a negative effect on lung function in 
smokers (28). However, Sparrow et al found that alcohol consumption was not associated with 
baseline or follow-up levels of FEV1 or FVC in 1,067 men (29). 
 Several cross-sectional studies have reported a positive association between alcohol 
intake and allergic sensitization (9, 11, 12). However, Assing et al found no association between 
alcohol intake and skin prick test positivity among 1668 students (8). The association between 
alcohol intake and incident allergic sensitization in cohort studies is even more controversial (6, 15). 
In a study of 5870 women aged 20–29 years, Bendtsen et al (16) found that self- reported alcohol 
consumption was positively associated with the risk of developing perennial allergic rhinitis but not 
seasonal allergic rhinitis. The association of moderate and excessive alcohol intake with higher 
serum levels of total IgE is more consistent (4-6, 9, 12, 13). A high consumption of alcohol may 
also increase IgE sensitization to cross-reactive carbohydrate determinants, and specific IgE results 
should be interpreted with caution in heavy alcohol drinkers (30). In addition, experimental alcohol 
administration to rodents induces an increase of serum IgE concentrations (19). Moreover, cessation 
of alcohol consumption in heavy drinkers is shortly followed by a decrease of serum IgE 
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concentrations (4, 13). In a Mendelian Randomization study of 111,408 persons from the general 
population, Nordestgaard et al found that genetically assessed higher alcohol intake was positively 
associated with total IgE (but not with allergic disease) (31).  
 In accordance with previous studies, we found that the rs1229984 was strongly 
associated with drinking status and alcohol intake which shows that rs1229984 is well-suited as a 
genetic instrument of alcohol intake (20). We used a standardized analytical protocol to increase 
reliability and robustness of the findings. To avoid confounding by population stratification, we 
included Europeans only and adjusted for population structure using principal components when 
possible. Since this covered most of the participants, we regard confounding by stratification to be 
of minor concern. We used objective markers of allergic sensitization, serum total IgE and lung 
function which may be more reliable than self-reported measures in certain situations. Using 
Mendelian randomization has several shortcomings, e.g., the observational analysis of ever versus 
never drinkers cannot be mimicked using this approach. Since the genotype explains only a small 
part of the variation in alcohol consumption, Mendelian randomization has lower power that 
traditional observational studies for comparable study sizes, i.e. Mendelian randomization studies 
need very large samples to be adequately powered. A limitation of the study is the use of mostly 
self-reported hay fever and asthma rather than clinical diagnoses or measurements. A non-
differential misclassification of a binary outcome is likely to attenuate associations towards the null. 
We also defined alcohol consumption from self-report but the validity compared with alternative 
measurements has previously been found to be reasonable (32). The hay fever variable in the UK 
Biobank included eczema. Therefore, we assessed two additional hay fever variables from the UK 
Biobank with similar results which indicates that the misclassification did not substantially bias our 
results. The main weaknesses of the additional hay fever variables were the fact that one was 
measured at follow-up in 2015 and in a subgroup only, limiting the available sample size; and the 
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other was based on self-reported medication rather than a doctor-diagnosed hay fever. Of note, 
alcohol intake did not distinguish between, e.g., beer and wine. We may have lacked power to show 
a similar association between alcohol and serum total IgE. It would be of interest to also study 
extreme exposure to alcohol, as seen in alcoholics. However, such individuals would also differ 
more substantially from the rest of the population with regard to potential confounders such as 
genetics of alcohol dependence and socioeconomic factors. The present study focused on the 
exposure levels in the normal range and in a population-based setting. It is important to 
acknowledge that the present study does not investigate effects of exposure to alcohol in childhood, 
before use of alcohol, and thus only relates to cases of asthma/hay fever that develop after start of 
alcohol use. However, it is increasingly being recognized that many cases of hay fever and asthma 
have their onset in adolescence or later in adulthood. Moreover, a factor that exacerbate or influence 
duration of a disease could also increase the prevalence of disease. 
 In conclusion, observational analyses found that ever-drinking vs. non-drinking was 
positively associated with hay fever and inversely with asthma but not with allergic sensitization, 
and serum total IgE. In contrast, genetic predisposition to consume more alcohol did not affect risk 
of hay fever, asthma, allergic sensitization, or serum levels of total IgE. The discrepancy of results 
between observational and Mendelian randomization analyses could be due to potential residual 
confounding, e.g., by socioeconomic factors or lifestyle factors. Our results challenge the concept of 
a risk-increasing effect of alcohol consumption on allergic disease and asthma. 
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Table 1. Overview of collaborating studies 
Study name Year N Age, median (IQR) % males Place 
1936-cohort (33) 1976–77 592 60.5 (60.2, 60.8) 47.3 Copenhagen, Denmark 
Monica10 (33) 1993–94 2262 52.0 (42.1, 61.9) 49.7 Glostrup, Copenhagen, Denmark 
Allergy98 (33) 1997–98 1148 38.0 (28.7, 51.3) 45.6 Western Copenhagen, Denmark 
Inter99 (33) 1999–01 4880 45.1 (40.0, 50.2) 49.0 Copenhagen area, Denmark 
Health2006 (34) 2006–08 2818 50.0 (40.0, 60.0) 45.0 Copenhagen area, Denmark 
DanFunD (35) 2012–15 7093 54 (44, 63) 46.3 Copenhagen area, Denmark 
GOYA Males (36) 1992–94 790 46 (41, 53) 100 Copenhagen area, Denmark 
1958 BC (37) 2000 2420 42 (42, 42) 52.1 England, Scotland and Wales 
KORA (38) 1997–98 1255 49.0 (39.0, 59.0) 49.1 Augsburg, Germany 
NEO (39) 2008–12 5557 57.0 (51.0, 61.0) 48.3 Leiden, Netherlands 
NSHD (40) 1999 2675 53 (53, 53) 49.9 England, Scotland and Wales 
Prosper (41) 1997–99 5504 75.0 (72.4, 77.9) 48.3 Scotland, Ireland, Netherlands 
UK Biobank (42) 2006–10 407767 58 (51, 63) 46.0 United Kingdom 
Rotterdam (43) 1990–93 7977 62.5 (58.2, 70.5) 43.0 Rotterdam, Netherlands 
SHIP (44) 1997–01 3725 50.0 (36.0, 62.0) 48.7 West Pomerania, Germany 
SHIP TREND (45) 2008–12 986 50.0 (40.0, 61.0) 43.8 West Pomerania, Germany 
CCH (46) 1991–94 8985 60.5 (47.8, 70.3) 44.3 Copenhagen area, Denmark 
Abbreviations: Allergy98, Copenhagen Allergy study; 1958 BC, British 1958 Birth Cohort; CCH, Copenhagen City 
Heart Study; GOYA, Genomics of extremely Overweight Young Adults; Inter99, Intervention 1999; IQR, interquartile 
range; KORA, Cooperative Health Research in the Region of Augsburg; NEO, Netherlands Epidemiology of Obesity; 
NSHD, National Survey of Health and Development; SHIP, Study of Health in Pomerania. 
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Figure 1.  
Random effects meta-analysis of the associations between the rs1229984 genotype (major homozygotes vs. minor 
homozygotes and heterozygotes) and the logarithm transformed alcohol intake (see heterogeneity in Supplementary 
Figure 1). Abbreviations: Allergy98, Copenhagen Allergy study; 1958 BC, British 1958 Birth Cohort; CCH, 
Copenhagen City Heart Study; Inter99, Intervention 1999; NEO, Netherlands Epidemiology of Obesity; NSHD, 
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Figure 2. 
Random effects meta-analyses of observational and instrumental variable estimates of the sex- and age-adjusted 
associations of alcohol status and -intake and genetically assessed alcohol intake, respectively, and hay fever, asthma, 
and allergic sensitization (see heterogeneity in Supplementary Figure 2–4 and 6–8). Numbers in the instrumental 
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Figure 3. 
Random effects meta-analyses of observational and instrumental variable estimates of the sex- and age-adjusted and 
sex-stratified associations of alcohol status and -intake and genetically assessed alcohol intake, respectively, and serum 
total IgE (see heterogeneity in Supplementary Figure 5 and 9). Numbers in the instrumental variable analyses refer to 
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